NIVF(NIVF)
NIVF
No analyst ratings available
No analyst price targets available for NIVF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $65M | $180M | $271M |
| Low | $65M | $180M | $271M |
| High | $65M | $180M | $271M |
| EBITDA Avg | $17M | $48M | $73M |
| Low | $17M | $48M | $73M |
| High | $17M | $48M | $73M |
| EBIT Avg | $15M | $41M | $61M |
| Low | $15M | $41M | $61M |
| High | $15M | $41M | $61M |
| Net Income Avg | $3M | $5M | $9M |
| Low | $3M | $5M | $9M |
| High | $3M | $5M | $9M |
| EPS Avg | $4.74 | $9.34 | $14.70 |
| Low | $4.74 | $9.34 | $14.70 |
| High | $4.74 | $9.34 | $14.70 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $3M | $20M | $45M |
| Low | $3M | $20M | $45M |
| High | $3M | $20M | $45M |
| EBITDA Avg | $771,950 | $5M | $12M |
| Low | $771,950 | $5M | $12M |
| High | $771,950 | $5M | $12M |
| EBIT Avg | $647,303 | $5M | $10M |
| Low | $647,303 | $5M | $10M |
| High | $647,303 | $5M | $10M |
| Net Income Avg | $109M | $1M | $2M |
| Low | $109M | $1M | $2M |
| High | $109M | $1M | $2M |
| EPS Avg | $185.40 | $2.02 | $2.72 |
| Low | $185.40 | $2.02 | $2.72 |
| High | $185.40 | $2.02 | $2.72 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |